|
|
MarketView
Events defining the day's trading activity on Wall Street
Lauren Rudd
Monday, January 26, 2009
Summary
The major stock equity indexes chalked up a small
gain on Monday in uneasy trading on Monday, with the gains due largely
to the news of a $68 billion takeover in the drug industry that offset a
grim warning about the year ahead from Caterpillar and worries over the
state of the financial sector. Pfizer, the world's largest
pharmaceutical company, said it had agreed to acquire rival Wyeth for
about $68 billion, suggesting that some companies are attractively
valued after a dismal 2008. Pfizer fell 10.3 percent to $15.65 on worries over
what benefits might or might not result from the acquisition, which had
been rumored since last week. It is the largest non-financial deal since
March 2008. Wyeth closed down 0.8 percent at $43.39. Caterpillar was the biggest drag on the Dow Jones
industrial average after the company forecast that its 2009 profit would
decline significantly from 2008. The company also said that it planned
to eliminate nearly 20,000 jobs. Caterpillar ended the day down 8.4
percent to close at $32.67. Home Depot announced that it also was facing deep job
cuts, with the world's largest home-improvement retailer reducing its
workforce by 7,000. The Dow component rose 4.7 percent to $22.73.
Companies across all sectors have been chopping jobs as they deal with
slowing consumer demand and the fallout from the global economic
downturn. There was also a rare piece of good news for the
recession-hit economy in that sales of existing homes rose unexpectedly
jumped by 6.5 percent in December. Nonetheless, financial stocks turned
lower in the afternoon and capped gains over concern on whether the
sector, which is at the heart of the credit crisis, will need to raise
yet more capital. Among financial-sector laggards, Regions Financial
fell 12 percent to close at $4.10 after an influential banking analyst
said Regions may slash its dividend by 90 percent. More Mixed
Economic News An unexpected improvement in home sales provided a
rare dose of good economic news on Monday, but companies continued to
wield the axe on jobs as the year-long recession inflicted more pain.
The pace of sales of previously owned homes rose for the first time
since September and inventory declined, a bit of positive news amid a
disastrous housing market crash that has chilled growth, sent
unemployment soaring and sharply eroded household wealth. Sales of previously owned
December existing-home sales were largely driven by
distressed sales, which dragged the median national home price down 15.3
percent from the year earlier to $175,400. The chief economist of the National Association of
Realtors, Lawrence Yun, said it was the largest price drop since NAR
started keeping records in 1968 and probably the largest since the Great
Depression. "There is pent-up demand, which could be unleashed
with the right stimulus. The Obama administration and Congress need to
move fast ... to stabilize home prizes and set the foundation for a
sustainable economic recovery," said Yun. Analysts were also heartened by the 11.7 percent drop
in the inventory of existing homes for sale to 3.68 million units from
4.16 million in November. That translated into 9.3 months of supply at
December's sales pace. The supply stood at 11.2 months' worth in
November. Meanwhile, the relentless wave of layoffs continued
on Monday as Caterpillar announced nearly 20,000 job cuts and Pfizer
said it would reduce the combined work force of itself and Wyeth by
about 130,000 or 15 percent. Separately, the Conference Board said its index of
leading economic indicators rose 0.3 percent, beating expectations of a
0.3 percent decline. The rise in the Conference Board's index of leading
economic indicators is credited to the improvement in credit markets
thanks to action by the Federal Reserve. The Fed has cut interest rates almost to zero and
pumped hundreds of billions of dollars into financial markets to keep
them operating. The Fed meets on Tuesday and Wednesday and is expected
to hold its target range for the key overnight federal funds rate steady
at zero to 0.25 percent. Sales
Increase At McDonald’s McDonald's quarterly profit number exceeded
estimates, but stifled some enthusiasm when it said that growth in some
overseas markets will soften as economies across the globe feel the
effects of our recession. The company posted a 5.8 percent rise in
worldwide December sales at restaurants open at least 13 months.
McDonald’s shares ended the day 0.65 percent at $58.40, but fell to
$58.22 in after hours trading. McDonald’s results are still ahead of most other
restaurant operators, but mark a slowdown from the company's own
November and October results, when McDonald's said same-store sales rose
7.7 percent and 8.2 percent, respectively. Fourth-quarter net income fell 23 percent to $985.3
million, or 87 cents per share, from $1.27 billion, or $1.06 per share,
a year earlier, when results included a large tax-related benefit.
McDonald's cited a "softening" in its business in Company executives said the world's largest economies
are sliding simultaneously into recession, but that McDonald's
same-store sales continue to be strong in January, with each area of the
world reporting positive results. "Our model remains recession resistant," Chief
Executive Jim Skinner said on a conference call with analysts. McDonald's, which offers a range of menu items for
$1, has cemented its lead position by appealing to budget-conscious
diners struggling with rising unemployment and sharp drops in home and
investment values. Revenue fell 3 percent to $5.57
billion, with McDonald’s stating that it was hit by a stronger dollar in
many foreign markets, including In McDonald's said its U.S. business benefited from the
addition of the Southern Style Chicken biscuit and sandwich, improved
service at its drive-through windows, and the expansion of its high-end
coffee drinks. For 2009, McDonald's forecast capital spending of
$2.1 billion, with about half of the total being invested in existing
restaurants and the rest being used to open about 1,000 new restaurants. It forecast 2009 food costs would rise 5 percent to
5.5 percent in the
Dow Chemical
Gets Cold Feet Dow Chemical has refused to close on its $15.3
billion takeover offer for rival Rohm and Haas by Tuesday, breaking a
key condition of the merger and sparking speculation that the deal might
collapse. At the same time, Rohm and Haas sued Dow on Monday, arguing
that the chemical company has no legal basis to walk away from the deal
and asking a Dow said it remains interested in discussions to find
a way to complete the deal but that the recent economic downturn has
made closing untenable at this time. "Dow Chemical has a long history of
resiliency in responding to changing market conditions, and that
resiliency continues, but the world has changed significantly and we
still do not see the bottom of this unprecedented demand destruction,"
Dow Chief Executive Andrew Liveris said in a statement. Dow's planned takeover of Rohm and Haas, a specialty
chemicals company, has been clouded with uncertainty since Last summer Dow agreed to buy Rohm and Haas for $78 a
share, a 74 percent premium, to broaden its product offerings in
higher-margin markets such as paints, coatings and electronic materials. However, chemical companies have been hurt by the
weakening economy as demand from industries they supply, such as autos,
housing and electronics, has fallen drastically. They have also seen a
slowdown in many emerging regions, areas that had been driving growth
for chemicals in recent quarters. Dow and Rohm and Haas have both announced job cuts
and other cost-cutting measures since their deal was announced. Nevertheless, if the merger is not completed on a
timely basis, Dow faces a "ticking fee" that requires it to pay Rohm and
Haas about $100 million for every month it does not close the
transaction. At the same time, lawyers have said the merger agreement is
very tight and Dow, the largest Under the merger agreement, the companies were to
close the merger within two business days following final regulatory
approval, which came on Friday. However, in its lawsuit, Rohm said that
Dow has refused to commit to closing at all. It said that Liveris told
Rohm that Dow believed it would be able to determine whether it could
close the merger by June 30. Shares of Rohm and Haas tumbled $8.37 or 12.7 percent
to $57.45 on the New York Stock Exchange, while Dow shares fell 5.6
percent to $13.53.
|
|
|
MarketView for January 26
MarketView for Monday, January 26